Aktis Oncology, Inc.

AKTS · Healthcare

$25.99

Markedsværdi: 1.45B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Aktis Oncology, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

MT Newswires19. aug. 2026, 15.42

Aktis Oncology Seen Advancing Targeted Radiation-Based Cancer Drugs, Wedbush Says

24/7 Wall St.19. aug. 2026, 12.10

Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play

MT Newswires19. aug. 2026, 11.22

Wedbush Initiates Aktis Oncology at Outperform With $35 Price Target

MT Newswires19. aug. 2026, 10.12

BMO Capital Initiates Akoustis Technologies at Outperform